Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Numerical study on the effect of individual variations on inhaled drug particle deposition distribution in grouped realistic inhaler-airway models

Lixing Zhang, Gang Guo, Zhenbo Tong, Ya Zhang and Aibing Yu
Powder Technology 457 120881 (2025)
https://doi.org/10.1016/j.powtec.2025.120881

Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting

Mathieu Molimard, Ioannis Kottakis, Juergen Jauernig, Sonja Lederhilger and Ivan Nikolaev
Clinical Drug Investigation 41 (5) 415 (2021)
https://doi.org/10.1007/s40261-021-01021-w

Effect of pharmacist‐led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta‐analysis

Xiaona Jia, Shuang Zhou, Daohuang Luo, et al.
Journal of Clinical Pharmacy and Therapeutics 45 (5) 904 (2020)
https://doi.org/10.1111/jcpt.13126

Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes

Gabriella Gálffy, Maria Szilasi and Lilla Tamási
Pulmonary Therapy 5 (2) 165 (2019)
https://doi.org/10.1007/s41030-019-0097-7

Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial

Claudia Gregoriano, Thomas Dieterle, Anna-Lisa Breitenstein, et al.
RESPIRATORY RESEARCH 19 (1) (2018)
https://doi.org/10.1186/s12931-018-0936-3

Pharmacist‐led intervention study to improve inhalation technique in asthma and COPD patients

Andrea Hämmerlein, Uta Müller and Martin Schulz
Journal of Evaluation in Clinical Practice 17 (1) 61 (2011)
https://doi.org/10.1111/j.1365-2753.2010.01369.x

Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol

Richard Pavkov, Stefan Mueller, Katrin Fiebich, et al.
Current Medical Research and Opinion 26 (11) 2527 (2010)
https://doi.org/10.1185/03007995.2010.518916

Existe-t-il des spécificités chez les femmes atteintes de BPCO ?

C. Raherison, E. Biron, C. Nocent-Ejnaini, et al.
Revue des Maladies Respiratoires 27 (6) 611 (2010)
https://doi.org/10.1016/j.rmr.2010.04.006

The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease

P. Quinet, C.A. Young and F. Héritier
Annals of Physical and Rehabilitation Medicine 53 (2) 69 (2010)
https://doi.org/10.1016/j.rehab.2009.11.001

Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD

Federico Lavorini, Antoine Magnan, Jean Christophe Dubus, et al.
Respiratory Medicine 102 (4) 593 (2008)
https://doi.org/10.1016/j.rmed.2007.11.003

Inhalation devices for long-acting β2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

Mathieu Molimard, Denise Till, Stephan Stenglein, Dilraj Singh and Markus Krummen
Current Medical Research and Opinion 23 (10) 2405 (2007)
https://doi.org/10.1185/030079907X219698

Pharmacological Approach to Evaluate Aerosol Pulmonary Deposition

Pierre-Olivier Girodet and Mathieu Molimard
Journal of Aerosol Medicine 18 (2) 183 (2005)
https://doi.org/10.1089/jam.2005.18.183